Putnam Investments LLC Amylyx Pharmaceuticals, Inc. Transaction History

Putnam Investments LLC

  • $73 Billion
  • Q4 2023

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023
SELL
$18.08 - $23.45 $7,268 - $9,426
-402 Reduced 0.86%
46,460 $850,000
Q2 2023

Aug 14, 2023
SELL
$20.98 - $31.42 $30,609 - $45,841
-1,459 Reduced 3.02%
46,862 $1.01 Million
Q1 2023

May 22, 2023
BUY
$27.71 - $40.93 $700,758 - $1.04 Million
25,289 Added 109.8%
48,321 $1.42 Million
Q4 2022

Feb 14, 2023
SELL
$29.75 - $39.26 $386 - $510
-13 Reduced 0.06%
23,032 $851,000
Q3 2022

Nov 14, 2022
BUY
$17.15 - $30.92 $395,221 - $712,551
23,045 New
23,045 $649,000

Others Institutions Holding AMLX

# of Institutions
139
Shares Held
46.5M
Call Options Held
226K
Put Options Held
909K
View Full List

About Amylyx Pharmaceuticals, Inc.

AMLX Quotes by TradingView
  • Ticker AMLX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 58,533,200
  • Market Cap $290M
  • Description
  • Amylyx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, engages in developing various therapeutics for amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases. The company's product pipeline includes AMX0035, a dual UPR-Bax apoptosis inhibitor composed of sodium phenylbutyrate and taurursodiol for the treatment...
More about AMLX
Track This Portfolio

Track Putnam Investments LLC Portfolio

Follow Putnam Investments LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Putnam Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Putnam Investments LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email